Nosocomial colonization and infection by Achromobacter xylosoxidans.
AUTOR(ES)
Reverdy, M E
RESUMO
Achromobacter xylosoxidans, a bacterial species named in 1971, is often isolated from aqueous environments, but little has been reported about its pathogenicity in humans, its epidemiological pattern, and its susceptibility to antibiotics and antiseptics. We were faced with an epidemic caused by this microorganism for 18 months in an intensive care unit. Two patients had fatal infections and 37 others were colonized. The source was the deionized water of the hemodialysis system. The 46 isolates were identified by comparison with the reference strain A. xylosoxidans ATCC 27061. The characteristic cellular fatty acids of this species were demonstrated by gas-liquid chromatography. The minimal inhibitory concentrations of 27 antibiotics were determined. The isolates were susceptible to only two: moxalactam at 4 micrograms/ml and ceftazidime at 8 micrograms/ml. The minimal bactericidal concentrations of one disinfectant and three antiseptics were: sodium hypochloride, 109 micrograms/ml; chlorhexidine digluconate in ethanol solution, 15 to 125 micrograms/ml; polyvinylpyrrolidone iodine, 750 micrograms/ml; and iodine ethanol, 312 to 625 micrograms/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=271003Documentos Relacionados
- Neonatal meningitis caused by Achromobacter xylosoxidans.
- Serological classification of Achromobacter xylosoxidans.
- Corneal ulcer due to Achromobacter xylosoxidans.
- Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
- Clinical and laboratory characteristics of Achromobacter xylosoxidans infection.
